Atea Pharmaceuticals (AVIR) Other Non-Current Assets (2019 - 2026)

Atea Pharmaceuticals' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 30.63% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (down 30.63% YoY), while the FY2025 annual figure was $3.1 million, up 1491.88% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $3.0 million, down from $3.1 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $5.5 million in Q3 2025, with the low at $197000.0 in Q4 2024.
• The 5-year median for Other Non-Current Assets is $1.4 million (2023), against an average of $1.7 million.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets tumbled 85.89% in 2024, then surged 1491.88% in 2025.
• Atea Pharmaceuticals' Other Non-Current Assets stood at $198000.0 in 2022, then surged by 605.05% to $1.4 million in 2023, then sank by 85.89% to $197000.0 in 2024, then soared by 1491.88% to $3.1 million in 2025, then declined by 2.81% to $3.0 million in 2026.
• Business Quant data shows AVIR's Other Non-Current Assets at $3.0 million in Q1 2026, $3.1 million in Q4 2025, and $5.5 million in Q3 2025.